ETFS Holding Actavis Inc

 
ETF Quotes for ETFS Holding Actavis Inc top ^
  • Holdings: Johnson & Johnson , Pfizer Inc , Merck & Co Inc , Bristol-Myers Squibb Company , Actavis PLC ,
  • Morningstar Rating: 4 Stars
Sign-up for ihe investment picks
  • Holdings: Gilead Sciences Inc , Southwest Airlines Co , Tesoro Corp , Actavis PLC , Marathon Petroleum Corp ,
  • Morningstar Rating: 5 Stars
Sign-up for fwdd investment picks
  • Holdings: Valeant Pharmaceuticals International Inc , Actavis PLC , Micron Technology Inc , Microsoft Corp , Baidu Inc ADR ,
Sign-up for alfa investment picks
  • Holdings: Keurig Green Mountain Inc , Southwest Airlines Co , Facebook Inc Class A , Vertex Pharmaceuticals Inc , Actavis PLC ,
  • Morningstar Rating: 5 Stars
Sign-up for rpg investment picks
  • Holdings: Medivation Inc , Cooper Companies , Actavis PLC , Illumina Inc , Gilead Sciences Inc ,
  • Morningstar Rating: 2 Stars
Sign-up for pth investment picks
  • Holdings: Nike Inc Class B , Actavis PLC , Burlington Stores Inc , Endo International PLC , Sprint Corp Series 1 ,
Sign-up for guru investment picks

 
News Articles for Actavis Inc top ^
- Potential Treatment For Patients With Complicated Urinary Tract Infections(cUTI) and Complicated Intra-Abdominal Infections (cIAI) - DUBLIN , Sept.
Sign-up for Actavis Announces FDA Acceptance of the NDA Filing for Ceftazidime-Avibactam, a Qualified Infectious Disease Product investment picks
- Potential Treatment of Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) in Men and Women Granted Priority Review Status - DUBLIN , Sept.
Sign-up for Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline investment picks
SAN FRANCISCO and DUBLIN , July 21, 2014 /PRNewswire/ -- Medicines360, a non-profit women's health pharmaceutical company, and Actavis plc (NYSE: ACT) , a leading global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Medicines360's New Drug Application (NDA) for Levosert ™ (levonorgestrel), a hormonal intrauterine contraceptive (IUC) for use by women to prevent pregnancy.
Sign-up for Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert™ IUD investment picks
- Second Quarter 2014 GAAP Earnings Per Diluted Share of $0.28 - - 82% Increase in Second Quarter 2014 Adjusted EBITDA to $862 million - DUBLIN , Aug.
Sign-up for Actavis Net Revenue Increases 34% to $2.67 Billion in Second Quarter 2014; Non-GAAP EPS Increases 70% to $3.42 investment picks
DUBLIN , Aug.
Sign-up for Actavis Confirms Generic Neupro® Patent Challenge investment picks
DUBLIN , Sept.
Sign-up for Actavis Confirms Generic Butrans® Patent Challenge investment picks
Actavis PLC (ACT) reportedly is in talks to purchase Salix Pharmaceuticals Ltd.
Sign-up for Actavis reportedly in talks to buy Salix Pharma investment picks
By Jonathan D.
Sign-up for Pfizer held takeover talks with Actavis investment picks
Pfizer Inc. (PFE) has contacted Actavis PLC (ACT) to indicate its interest in a potential acquisition, Bloomberg reported Tuesday, citing people with knowledge of the matter.
Sign-up for Pfizer Has Contacted Actavis About Potential Deal, Parties Not In Formal Talks -Bloomberg investment picks
Shares of Actavis Plc (ACT) rose more than 2% in afternoon trade Tuesday, after Bloomberg News reported that the company was approached by Pfizer Inc. (PFE) to discuss a possible deal.
Sign-up for Actavis shares rise on report of Pfizer approach investment picks
By Jonathan D.
Sign-up for Botox maker Allergan rejected Actavis takeover bid investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Actavis Inc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding ABB  |  Next: ETFS Holding Activision Blizzard, Inc.